✦ LIBER ✦

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

✍ Scribed by Ross L. Levine; Martha Wadleigh; Jan Cools; Benjamin L. Ebert; Gerlinde Wernig; Brian J.P. Huntly; Titus J. Boggon; Iwona Wlodarska; Jennifer J. Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C. Lee; Stacey Gabriel; Thomas Mercher; Alan D’Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A. Mesa; Ayalew Tefferi; James D. Griffin; Michael J. Eck; William R. Sellers; Matthew Meyerson; Todd R. Golub; Stephanie J. Lee; D. Gary Gilliland

Book ID: 113523550
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 459 KB
Volume: 7
Category: Article
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2005.03.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leukemogenic risk of hydroxyurea therapy

Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

✍ Nand, Sucha; Stock, Wendy; Godwin, John; Fisher, Susan Gross 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

In polycythemia Vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not a

TET2 mutations and their clinical correl

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

✍ Tefferi, A; Pardanani, A; Lim, K-H; Abdel-Wahab, O; Lasho, T L; Patel, J; Gangat 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

The JAK2V617F tyrosine kinase mutation i

The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

✍ Ayalew Tefferi; Terra L. Lasho; Susan M. Schwager; David P. Steensma; Ruben A. M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Megakaryopoiesis and platelet function i

Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation

✍ Norimichi Hattori; Kunihiko Fukuchi; Hidetoshi Nakashima; Takashi Maeda; Daisuke 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 260 KB

Evaluation of the JAK2-V617F gene mutati

Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera

✍ Karkucak, Mutlu; Yakut, Tahsin; Ozkocaman, Vildan; Ozkalemkas, Fahir; Ali, Ridva 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 193 KB

The JAK2 V617F allele burden in essentia

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype

✍ Thomas Stauffer Larsen; Niels Pallisgaard; Michael Boe Møller; Hans Carl Hasselb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB